Precision Microbiome: A New Era of Targeted Therapy with Core Probiotics
Research · 2025-01 · 8
DOI: 10.34133/research.0658 ↗Kurz gefasst
Editorial in der Zeitschrift Research, online erschienen am 26.03.2025. Verfasst von Xiuyu Fang und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Animal Science and Technology, Northeast Agricultural University, Harbin 150030, China. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- College of Animal Science and Technology, Northeast Agricultural University, Harbin 150030, China.
- Zhejiang Provincial Key Laboratory of Pancreatic Disease of The First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou 310029, Zhejiang, China.
- Yu-Yue Pathology Scientific Research Center, Jinfeng Laboratory, Chongqing 401329, China.
- State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China.
ORCID-Profile: Yuan Huang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Fang, X., Wang, Y., Wei, H., & Huang, Y. (2025). Precision Microbiome: A New Era of Targeted Therapy with Core Probiotics. Research, 8. https://doi.org/10.34133/research.0658
Vancouver
Fang X, Wang Y, Wei H, Huang Y. Precision Microbiome: A New Era of Targeted Therapy with Core Probiotics. Research. 2025;8. doi:10.34133/research.0658
BibTeX
@article{Fang2025,
author = {Fang, Xiuyu and Wang, Yuhao and Wei, Hong and Huang, Yuan},
title = {Precision Microbiome: A New Era of Targeted Therapy with Core Probiotics},
journal = {Research},
year = {2025},
volume = {8},
doi = {10.34133/research.0658}
}
EUVIMED